Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line

被引:274
作者
Min, Y.-D.
Choi, C.-H.
Bark, H.
Son, H.-Y.
Park, H.-H.
Lee, S.
Park, J.-W.
Park, E.-K.
Shin, H.-I.
Kim, S.-H. [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Taegu 700422, South Korea
[2] Chosun Univ, Sch Med, Dept Surg, Kwangju 501759, South Korea
[3] Chosun Univ, Sch Med, Dept Pharmacol, Kwangju 501759, South Korea
[4] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Taegu 700422, South Korea
[5] Kyungpook Natl Univ, Sch Dent, Dept Pathol & Regenerat Med, Taegu 700422, South Korea
关键词
quercetin; mast cell; allergic inflammation; pro-inflammatory cytokine;
D O I
10.1007/s00011-007-6172-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective and design: Mast cell-mediated allergic inflammation is involved in many diseases such as asthma, sinusitis, and rheumatoid arthritis. Mast cells induce production of pro-inflammatory cytokines with immune regulatory properties. We investigated the effect of quercetin on the expression of pro-inflammatory cytokines in human mast cell line, HMC-1. Methods: HMC-1 cells were stimulated with phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187 (PMACI). Results: Quercetin decreased the gene expression and production of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, and IL-8 in PMACI-stimulated HMC-1 cells. Quercetin attenuated PMACI-induced activation of NF-kappa B and p38 mitogen-activated protein kinase. Conclusion: Our study provides evidence that quercetin may suitable for the treatment of mast cell-derived allergic inflammatory diseases.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 38 条
[1]   Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1) [J].
Alexandrakis, M ;
Letourneau, R ;
Kempuraj, D ;
Grzybowska, KK ;
Huang, M ;
Christodoulou, S ;
Boucher, W ;
Seretakis, D ;
Theoharides, TC .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (06) :448-454
[2]   Mitogen-activated protein kinases [J].
Arbabi, S ;
Maier, RV .
CRITICAL CARE MEDICINE, 2002, 30 (01) :S74-S79
[3]   Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells [J].
Azzolina, A ;
Bongiovanni, A ;
Lampiasi, N .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3) :75-83
[4]  
Baldassare JJ, 1999, J IMMUNOL, V162, P5367
[5]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[6]  
Blackwell TS, 1997, J IMMUNOL, V158, P5934
[7]   ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA [J].
BUTTERFIELD, JH ;
WEILER, D ;
DEWALD, G ;
GLEICH, GJ .
LEUKEMIA RESEARCH, 1988, 12 (04) :345-355
[8]  
Choi Cheol-Hee, 2006, Korean Journal of Physiology & Pharmacology, V10, P101
[9]   MAST-CELLS AND THE ACTIONS OF FLAVONOIDS [J].
FOREMAN, JC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (06) :769-774
[10]   Mast cells as "tunable" effector and immunoregulatory cells: Recent advances [J].
Galli, SJ ;
Kalesnikoff, J ;
Grimbaldeston, MA ;
Piliponsky, AM ;
Williams, CMM ;
Tsai, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :749-786